Cytosite Biopharma Inc.
3 clinical trials · Sponsor
◉ Watch Cytosite Biopharma Inc.
| Record | Firm | Date |
|---|---|---|
| CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer (NCT07057349) | Cytosite Biopharma Inc. | 2025-09-01 |
| Study to Evaluate the Safety and Dosimetry of [68Ga]-NOTA-hGZP (CSB-111) PET Imaging in Healthy Human Volunteers. (NCT05285696) | Cytosite Biopharma Inc. | 2022-09-01 |
| Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors (NCT04169321) | Cytosite Biopharma Inc. | 2020-06-16 |
Track Cytosite Biopharma Inc. automatically
Every clearance here is in the API, with alerts when new ones post.